Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Miconazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved
Sponsor : m8 Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Licensing Agreement
m8 Pharmaceuticals and Vectans Pharma Enter Agreement
Details : m8 Pharmaceuticals and Vectans Pharma have signed an exclusive licensing agreement whereby m8 will have the rights to register and commercialize Loramyc® (miconazole) for Mexico and Brazil.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
February 18, 2020
Lead Product(s) : Miconazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Sponsor : m8 Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Licensing Agreement
LOOKING FOR A SUPPLIER?